Recombinant multi-species Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Alternative splicing results in multiple transcript variants encoding two different isoforms. The longer isoform acts as an apoptotic inhibitor and the shorter isoform acts as an apoptotic activator. [provided by RefSeq, Dec 2015]
The Alternative Names of target: Apoptosis regulator Bcl-X,BCL-XL,BCL-XL/S,BCL-xL,BCL2L,BCL2L1,BCLX,Bcl(X)L,Bcl-2-like protein 1,Bcl-X,Bcl-XL,Bcl-xL,Bcl-xl,Bcl2-L-1,Bcl2l,Bcl2l1,BclX,Bclx,PPP1R52,bcl-X,bcl-x,bcl-xl,bcl2-L-1
Go
to Bcl-XL/Bcl-xL/BCL2L1/BCL-xL products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0048-Ag-1/ GM-Tg-hg-IP0048-Ag-2 | Human Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Human |
| GM-Tg-rg-IP0048-Ag-1/ GM-Tg-rg-IP0048-Ag-2 | Rat Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Rat |
| GM-Tg-mg-IP0048-Ag-1/ GM-Tg-mg-IP0048-Ag-2 | Mouse Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Mouse |
| GM-Tg-cynog-IP0048-Ag-1/ GM-Tg-cynog-IP0048-Ag-2 | Cynomolgus/Rhesus macaque Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0048-Ag-1/ GM-Tg-felg-IP0048-Ag-2 | Feline Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Feline |
| GM-Tg-cang-IP0048-Ag-1/ GM-Tg-cang-IP0048-Ag-2 | Canine Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Canine |
| GM-Tg-bovg-IP0048-Ag-1/ GM-Tg-bovg-IP0048-Ag-2 | Bovine Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Bovine |
| GM-Tg-equg-IP0048-Ag-1/ GM-Tg-equg-IP0048-Ag-2 | Equine Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0048-Ag-1/ GM-Tg-hg-IP0048-Ag-2;
GM-Tg-rg-IP0048-Ag-1/ GM-Tg-rg-IP0048-Ag-2;
GM-Tg-mg-IP0048-Ag-1/ GM-Tg-mg-IP0048-Ag-2; GM-Tg-cynog-IP0048-Ag-1/ GM-Tg-cynog-IP0048-Ag-2; GM-Tg-felg-IP0048-Ag-1/ GM-Tg-felg-IP0048-Ag-2; GM-Tg-cang-IP0048-Ag-1/ GM-Tg-cang-IP0048-Ag-2; GM-Tg-bovg-IP0048-Ag-1/ GM-Tg-bovg-IP0048-Ag-2; GM-Tg-equg-IP0048-Ag-1/ GM-Tg-equg-IP0048-Ag-2 |
| Products Name | Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Bcl-XL/Bcl-xL/BCL2L1/BCL-xL |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Bcl-XL/Bcl-xL/BCL2L1/BCL-xL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.